Neuberger Berman Group
ADPT icon

Neuberger Berman Group’s Adaptive Biotechnologies ADPT Stock Holding History

Neuberger Berman Group’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.38M Buy
110,948
+284
+0.3% +$4.35K ﹤0.01% 1239
2026
Q1 		$1.54M Sell
110,664
-340,905
-75% -$5.43M ﹤0.01% 1264
2025
Q4 		$7.33M Buy
451,569
+348,445
+338% +$5.69M 0.01% 886
2025
Q3 		$1.54M Buy
103,124
+1,082
+1% +$13.2K ﹤0.01% 1229
2025
Q2 		$1.19M Buy
102,042
+62
+0.1% +$563 ﹤0.01% 1299
2025
Q1 		$758K Sell
101,980
-6,546
-6% -$50.3K ﹤0.01% 1409
2024
Q4 		$651K Hold
108,526
– – ﹤0.01% 1448
2024
Q3 		$556K Buy
108,526
+3,323
+3% +$14.5K ﹤0.01% 1483
2024
Q2 		$381K Buy
105,203
+4,399
+4% +$14K ﹤0.01% 1578
2024
Q1 		$324K Sell
100,804
-198,588
-66% -$768K ﹤0.01% 1621
2023
Q4 		$1.47M Sell
299,392
-124,074
-29% -$566K ﹤0.01% 1373
2023
Q3 		$2.31M Sell
423,466
-131,311
-24% -$868K ﹤0.01% 1058
2023
Q2 		$3.72M Sell
554,777
-67,862
-11% -$505K ﹤0.01% 957
2023
Q1 		$5.5M Sell
622,639
-8,230
-1% -$72.6K 0.01% 855
2022
Q4 		$4.82M Buy
630,869
+53,210
+9% +$414K ﹤0.01% 872
2022
Q3 		$4.11M Buy
577,659
+59,103
+11% +$557K ﹤0.01% 926
2022
Q2 		$4.2M Sell
518,556
-749,517
-59% -$6.59M ﹤0.01% 938
2022
Q1 		$17.6M Sell
1,268,073
-734,571
-37% -$11.5M 0.01% 695
2021
Q4 		$56.1M Sell
2,002,644
-251,084
-11% -$7.7M 0.04% 450
2021
Q3 		$76.5M Buy
2,253,728
+51,843
+2% +$1.87M 0.07% 365
2021
Q2 		$89.8M Buy
2,201,885
+99,140
+5% +$3.85M 0.08% 330
2021
Q1 		$84.6M Buy
2,102,745
+93,441
+5% +$5.06M 0.08% 329
2020
Q4 		$119M Buy
2,009,304
+161,352
+9% +$8.32M 0.12% 243
2020
Q3 		$89.9M Buy
1,847,952
+124,605
+7% +$5.24M 0.11% 261
2020
Q2 		$83.4M Buy
1,723,347
+1,225,502
+246% +$44.7M 0.1% 268
2020
Q1 		$13.8M Buy
+497,845
New +$13.9M 0.02% 583

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Neuberger Berman Group's ADPT Position: Q2 2026 in Review

Neuberger Berman Group increased its Adaptive Biotechnologies (ADPT) stake by 0.26% in Q2 2026, buying an estimated $4.35K and bringing the position to 110,948 shares worth $2.38M. The position accounts for ﹤0.01% of the portfolio, ranked #1239.

Neuberger Berman Group first reported a position in ADPT in Q1 2020 and has held it in 26 quarters since. The position peaked at $119M in Q4 2020. 301 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • Neuberger Berman Group held 110,948 shares of Adaptive Biotechnologies worth $2.38M as of Q2 2026.
  • Neuberger Berman Group bought 284 Adaptive Biotechnologies shares in Q2 2026, an estimated $4.35K.
  • Adaptive Biotechnologies made up ﹤0.01% of Neuberger Berman Group's portfolio in Q2 2026, its #1239 holding.
  • Neuberger Berman Group first reported a position in Adaptive Biotechnologies in Q1 2020 and has held it in 26 quarters since.
  • Neuberger Berman Group's Adaptive Biotechnologies position peaked at $119M in Q4 2020.
  • 301 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Neuberger Berman Group's 13F filing for Q2 2026, filed 13 Aug 2026.